Skip to main content
FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237705No data is associated with this publication.
Abstract
Background: Human basal-like breast cancer (BLBC) has a poor prognosis and is often identified by expression of the epidermal growth factor receptor (EGFR). BLBC remains a major clinical challenge because its pathogenesis is not well understood, thus hindering efforts to develop targeted therapies. Recent data implicate the forkhead box C1 (FOXC1) transcription factor as an important prognostic biomarker and functional regulator of BLBC, but its regulatory mechanism and impact on BLBC tumorigenesis remain unclear.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.